Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management

Share Article

Clinerion and the Alliance for Clinical Research Excellence and Safety (ACRES) have strategically allied to further the establishment of a shared global technology infrastructure enabling ACRES BlueCloud services so that stakeholders from sites, to CROs and research Sponsors can benefit from established innovative technology services such as those Clinerion provides.

News Image
"We ... are pleased to make our easy-to-implement, industry-hardened solutions in Risk-Based Quality Management and Patient Recruitment available to ACRES. We do this for free or at very attractive conditions", said Ulf Claesson, CEO of Clinerion

Clinerion, an eClinical technology services provider located in Basel, Switzerland, and the Alliance for Clinical Research Excellence and Safety (ACRES), a Cambridge, Massachusetts-based non-profit organization operating in the public interest and dedicated to building a global system to enhance quality, safety, integrity and operational effectiveness in biomedical product development and health research, are pleased to announce their partnership for accelerating patient recruitment and promoting risk-based quality management.

By aligning with ACRES integrated data source capabilities housing valuable study and site information, Clinerion's Quality Risk Radar will be able to significantly extend its support of risk-informed decision making during the clinical planning and execution process and thereby maintain and exceed study quality standards. Risk based Monitoring (RBM) becomes a reality when applying Clinerion's consulting and technology services as they enable all clinical research organizations to start projects quickly and rapidly pilot the new RBM approach and enabling technology by taking advantage of FREE and discounted services that Clinerion has pledged to ACRES.

Clinerion will provide to ACRES real-time access to millions of electronic health records (EHRs) coupled with the use of its Patient Recruitment System to find on average 30 times more trial candidates than conventional screening.

"We are delighted to join the ACRES Global Network and are pleased to make our easy-to-implement, industry-hardened solutions in Risk-Based Quality Management and Patient Recruitment available to ACRES. We do this for free or at very attractive conditions and we are convinced that this will translate into significant progress toward the common goals of enhancing quality and operational effectiveness in biomedical product development and health research," said Ulf Claesson, CEO of Clinerion.

ACRES COO, Matthew Whalen, noted, “Our relationship with Clinerion — as a Strategic Ally offering innovative solutions that already exist — demonstrates our ongoing commitment to improve clinical research processes globally and accountably. We are excited to be going forward as allies”.

About ACRES

The Alliance for Clinical Research Excellence and Safety (ACRES), a non-profit multi-sector alliance working in the public interest, brings together diverse stakeholders from across the clinical research enterprise and harnesses their expertise and investments to collaboratively build an open, integrated global system, based in principles of Accountable Research™. Adapting lessons from industries that have successfully implemented principles of systems and safety engineering, such as transportation, communications and information technology, this system will employ integrated information technologies and interoperable standards, policies and practices to enhance clinical research safety, quality and efficiency worldwide to benefit all stakeholders, especially patients.

About Clinerion

Clinerion is a Swiss-based technology services company with international operations offering scalable electronic patient recruitment and quality risk management solutions to increase efficiency and quality in clinical research. The company's patient recruitment solution connects to, aggregates and leverages existing electronic medical records. Following international privacy and confidentiality standards, Clinerion's solutions anonymize, enrich and normalize those records and facilitate real-time patient recruitment for clinical trials. Clinerion's Quality Risk Radar product leverages clinical research data, analyzes these data with leading risk management methodologies (FMEA) and facilitates risk control using risk intervention tools all based on ICH Q9 Guidance for Industry on Quality Risk Management.

Contact Information:

Mary F. Tobin, Ph D
Alliance for Clinical Research Excellence and Safety (ACRES)
Special Advisor to the President and Chief Executive Officer
http://www.acresglobal.net
mtobin(at)acresglobal(dot)net
+1 410-987-5509

Randy Ramin-Wright
Clinerion Ltd.
Head of Quality Risk Management
http://www.clinerion.com
randy.ramin-wright(at)clinerion(dot)com
+1 41-61-865-6060

Share article on social media or email:

View article via:

Pdf Print